EUBIOLOGICS CO., LTD.

Press Releases EuBiologics Co., Ltd.

Equities

A206650

KR7206650004

End-of-day quote Korea S.E. Other stock markets 03:30:00 14/05/2024 am IST			5-day change	1st Jan Change
12,840 ^KRW	-0.47%		-3.96%	+11.94%

29/01	Zimbabwe launches door-to-door cholera vaccination campaign	RE
2023	Pop Biotechnologies and Eubiologics' Eucorvac-19 Vaccine Hits Target in Phase 3 Trial	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

EuBiologics co.,Ltd - SNAP Platform enters Phase I clinical studies for RSV	13/05	AQ
Gavi and UNICEF welcome approval of new oral cholera vaccine	19/04	AQ
Gavi and Unicef Welcome Approval of New Oral Cholera Vaccine [press release]	19/04	AQ
What's Behind the Worldwide Shortage of Cholera Vaccines? for Starters, They're Only Made By One Company [analysis]	13/03	AQ
Gavi - Global vaccine alliance outlines path to sustainable cholera vaccine supply	23/23/23	AQ
POP Biotechnologies' SNAP Vaccine System Safe and Effective in a Phase II Clinical Trial for COVID-19	01/22/01	AQ
POP Biotechnologies' next-gen vaccine technology to enter COVID-19 phase III clinical trials	07/22/07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW